BioFortis

Gentris has selected BioFortis' Labmatrix and Qiagram software to manage samples and data collection and integration activities in its biorepository.

NEW YORK (GenomeWeb News) – The French government has provided €13.4 million ($17.4 million) to fund the Innovative MODels Initiative (IMODI), a partnership aimed at facilitating the development of new cancer treatments.

OpenEye has released AFITT 2.2.0, an application designed to help crystallographers fit ligands to observed data.

BioFortis said the foundation will use the platform to collect and manage patient specimen data and clinical information, track shipment status, analyze data from thousands of patient biospecimens, and view real-time study results from pre-built or ad hoc data queries.

Investigators at Rush University Medical Center will use BioFortis' Labmatrix to manage its biobank and biomarker data for research efforts focused on early detection and diagnosis of cancer and neurodegenerative diseases.

BioInform's Licensing Roundup: July and August's Software Deals

The software will be used to develop workflow-driven protocols to support specimen biobanking, biomarker discovery, and translational research.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.